Long term follow up of survivors of childhood cancer
References

1. Stiller CA. Aetiology and epidemiology. In: Pinkerton CR, Plowman PN, editors. Paediatric Oncology: Clinical practice and controversies. 2nd ed London;Chapman and Hall Medical:1997. 3-21. [back] [section 1.2] [section 1.4]

2. Bleyer WA. The impact of childhood cancer on the United States and the world. CA Cancer J Clin 1990;40(6):355-67. [back]

3. Mertens AC, Yasui Y, Neglia JP, Potter JD, Nesbit ME, Ruccione K, et al. Late mortality experience in five-year survivors of childhood and adolescent cancer: the Childhood Cancer Survivor Study. J Clin Oncol 2001;19(13):3163-72. [back]

4. Moller TR, Garwicz S, Barlow L, Falck Winther J, Glattre E, Olafsdottir G, et al. Decreasing late mortality among five-year survivors of cancer in childhood and adolescence: a population-based study in the Nordic countries. J Clin Oncol 2001;19(13):3173-81. [back]

5. Wallace WH, Blacklay A, Eiser C, Davies H, Hawkins M, Levitt GA, et al. Developing strategies for long term follow up of survivors of childhood cancer. BMJ 2001;323(7307):271-4. [back]

6. Abayomi OK, Sadeghi-Nejad A. The incidence of late endocrine dysfunction following irradiation for childhood medulloblastoma. Int J Radiat Oncol Biol Phys 1986;12:945-8. [back] [section 3.1] [section 3.2.2]

7. Albertsson-Wikland K, Lannering B, Marky I, Mellander L, Wannholt U. A longitudinal study on growth and spontaneous growth hormone (GH) secretion in children with irradiated brain tumors. Acta Paediatr Scand 1987;76:966-73. [back] [section 3.1] [section 3.2.2] [section 3.2.3]

8. Chin HW, Maruyama Y. Age at treatment and long-term performance results in medulloblastoma. Cancer 1984;53:1952-8. [back] [section 3.1] [section 3.2.2]

9. Clayton PE, Shalet SM. The evolution of spinal growth after irradiation. Clin Oncol (R Coll Radiol) 1991;3:220-2. [back] [section 3.1] [section 3.2.2]

10. Clayton PE, Shalet SM. Dose dependency of time of onset of radiation-induced growth hormone deficiency . J Pediatr 1991;118(2):226-8. [back] [section 3.1] [section 3.2.2]

11. Oberfield SE, Soranno D, Nirenberg A, Heller G, Allen JC, David R, et al. Age at onset of puberty following high-dose central nervous system radiation therapy. Arch Pediatr Adolesc Med 1996;150(6):589-92. [back] [section 3.1] [section 3.2.2] [section 4.2.2]

12. Ogilvy-Stuart AL, Wallace WH, Shalet SM. Radiation and neuroregulatory control of growth hormone secretion. Clin Endocrinol (Oxf) 1994;41(2):163-8. [back] [section 3.1] [section 3.2.2]

13. Clayton PE, Shalet SM, Morris-Jones PH, Price DA. Growth in children treated for acute lymphoblastic leukaemia. Lancet 1988;1(8583):460-2. [back] [section 3.1] [section 3.5.1]

14. DeVile CJ, Grant DB, Hayward RD, Stanhope R. Growth and endocrine sequelae of craniopharyngioma. Arch Dis Child 1996;75(2):108-14. [back]

15. Ogilvy-Stuart AL, Clayton PE, Shalet SM. Cranial irradiation and early puberty . J Clin Endocrinol Metab 1994;78(6):1282-6. [back]

16. Birkebaek NH, Fisker S, Clausen N, Tuovinen V, Sindet-Pedersen S, Christiansen JS. Growth and endocrinological disorders up to 21 years after treatment for acute lymphoblastic leukemia in childhood. Med Pediatr Oncol 1998;30(6):351-6. [back] [section 3.2.3] [section 3.2.5]

17. Shalet SM, Beardwell CG, Pearson D, Jones PH. The effect of varying doses of cerebral irradiation on growth hormone production in childhood. Clin Endocrinol (Oxf) 1976;5:287-90. [back]

18. Berglund G, Karlberg J, Marky I, Mellander L. A longitudinal study of growth in children with acute lymphoblastic leukemia. Acta Paediatr Scand 1985;74:530-3. [back]

19. Bramswig JH, Wegele M, von Lengerke HJ, Muller RP, Schellong G. The effect of the number of fractions of cranial irradiation on growth in children with acute lymphoblastic leukaemia. Acta Paediatr Scand 1989;78:296-302. [back]

20. Clayton PE, Shalet SM, Price DA. Growth response to growth hormone therapy following cranial irradiation. Eur J Pediatr 1988;147:593-6. [back] [section 3.2.3] [section 3.5.1]

21. Dacou-Voutetakis C, Kitra V, Grafakos S, Polychronopoulou S, Drakopoulou M, Haidas S. Auxologic data and hormonal profile in long-term survivors of childhood acute lymphoid leukemia. Am J Pediatr Hematol Oncol 1993;15:277-83. [back] [section 3.2.3] [section 3.4]

22. Davies HA, Didcock E, Didi M, Ogilvy-Stuart A, Wales JK, Shalet SM. Disproportionate short stature after cranial irradiation and combination chemotherapy for leukaemia. Arch Dis Child 1994;70(6):472-5. [back]

23. Davies HA, Didcock E, Didi M, Ogilvy-Stuart A, Wales JK, Shalet SM. Growth, puberty and obesity after treatment for leukaemia. Acta Paediatr Suppl 1995;411:45-50, discussion 51. [back] [section 3.2.3] [section 3.4] [section 4.2.2]

24. Holm K, Nysom K, Rasmussen MH, Hertz H, Jacobsen N, Skakkebaek NE, et al. Growth, growth hormone and final height after BMT. Possible recovery of irradiation-induced growth hormone insufficiency. Bone Marrow Transplant 1996;18:163-70. [back] [section 3.2.3] [section 3.2.4]

25. Katz JA, Pollock BH, Jacaruso D, Morad A. Final attained height in patients successfully treated for childhood acute lymphoblastic leukemia. J Pediatr 1993;123(4):546-52. [back] [section 3.2.3] [section 3.2.5]

26. Logghe KA, Bourguignon JP, Craen M, Benoit Y. Factors contributing to the impairment of growth in children with acute lymphoblastic leukemia. Horm Res 1988;30:62-7. [back]

27. Melin AE, Adan L, Leverger G, Souberbielle JC, Schaison G, Brauner R. Growth hormone secretion, puberty and adult height after cranial irradiation with 18 Gy for leukaemia. Eur J Pediatr 1998;157:703-7. [back] [section 3.2.3] [section 4.2.2]

28. Moell C, Marky I, Hovi L, Kristinsson J, Rix M, Moe PJ, et al. Cerebral irradiation causes blunted pubertal growth in girls treated for acute leukemia. Med Pediatr Oncol 1994;22(6):375-9. [back] [section 3.2.3] [section 3.2.5]

29. Robison LL, Nesbit MEJ, Sather HN, Meadows AT, Ortega JA, Hammond GD. Height of children successfully treated for acute lymphobastic leukemia:a report from the Late Effects Study Committee of Childrens Cancer Study Group. Med Pediatr Oncol 1985;13:14-21. [back]

30. Herber SM, Dunsmore IR, Milner RD. Final stature in brain tumours other than craniopharyngioma: effect of growth hormone. Horm Res 1985;22:63-7. [back] [section 3.2.3] [section 3.5.1]

31. Leiper AD, Stanhope R, Lau T, Grant DB, Blacklock H, Chessells JM, et al. The effect of total body irradiation and bone marrow transplantation during childhood and adolescence on growth and endocrine function. Br J Haematol 1987;67(4):419-26. [back] [section 3.2.3] [section 3.2.4] [section 6.1.5]

32. Sklar CA, Mertens AC, Walter A, Mitchell D, Nesbit ME, O’Leary M, et al. Changes in body mass index and prevalence of overweight in survivors of childhood acute lymphoblastic leukemia: role of cranial irradiation. Med Pediatr Oncol 2000;35:91-5. [back] [section 3.2.3] [section 6.1.1]

33. Leiper AD, Stanhope R, Kitching P, Chessells JM. Precocious and premature puberty associated with treatment of acute lymphoblastic leukaemia. Arch Dis Child 1987;62:1107-12. [back] [section 3.2.3] [section 4.2.2]

34. Crowne EC, Moore C, Wallace WH, Ogilvy-Stuart AL, Addison GM, Morris-Jones PH, et al. A novel variant of growth hormone (GH) insufficiency following low dose cranial irradiation. Clin Endocrinol (Oxf) 1992;36(1):59-68. [back]

35. Didcock E, Davies HA, Didi M, Ogilvy Stuart AL, Wales JK, Shalet SM. Pubertal growth in young adult survivors of childhood leukemia. J Clin Oncol 1995;13:2503-7. [back] [section 3.2.3] [section 4.2.2]

36. Clement-De Boers A, Oostdijk W, Van Weel-Sipman MH, Van den Broeck J, Wit JM, Vossen JM. Final height and hormonal function after bone marrow transplantation in children. J Pediatr 1996;129(4):544-50. [back]

37. Cohen A, van Lint MT, Uderzo C, Rovelli A, Lavagetto A, Vitale V, et al. Growth in patients after allogeneic bone marrow transplant for hematological diseases in childhood. Bone Marrow Transplant 1995;15(3):343-8. [back]

38. Cohen A, Rovelli A, Van-Lint MT, Uderzo C, Morchio A, Pezzini C, et al. Final height of patients who underwent bone marrow transplantation during childhood. Arch Dis Child 1996;74(5):437-40. [back]

39. Cohen A, Duell T, Socie G, van Lint MT, Weiss M, Tichelli A, et al. Nutritional status and growth after bone marrow transplantation (BMT) during childhood: EBMT Late-Effects Working Party retrospective data. European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 1999;23(10):1043-7. [back]

40. Cohen A, Rovelli A, Bakker B, Uderzo C, van Lint MT, Esperou H, et al. Final height of patients who underwent bone marrow transplantation for hematological disorders during childhood: a study by the Working Party for Late Effects-EBMT. Blood 1999;93(12):4109-15. [back]

41. Willi SM, Cooke K, Goldwein J, August CS, Olshan JS, Moshang T, Jr. Growth in children after bone marrow transplantation for advanced neuroblastoma compared with growth after transplantation for leukemia or aplastic anemia. J Pediatr 1992;120(5):726-32. [back]

42. Afify Z, Shaw PJ, Clavano-Harding A, Cowell CT. Growth and endocrine function in children with acute myeloid leukaemia after bone marrow transplantation using busulfan/cyclophosphamide. Bone Marrow Transplant 2000;25:1087-92. [back]

43. Katz JA, Chambers B, Everhart C, Marks JF, Buchanan GR. Linear growth in children with acute lymphoblastic leukemia treated without cranial irradiation. J Pediatr 1991;118:575-8. [back]

44. Makipernaa A, Dunkel L, Siimes MA. Growth after treatment of solid tumours in childhood. Acta Paediatr Scand 1990;79:817-22. [back]

45. Roman J, Villaizan CJ, Garcia-Foncillas J, Salvador J, Sierrasesumaga L. Growth and growth hormone secretion in children with cancer treated with chemotherapy. J Pediatr 1997;131(1 Pt 1):105-12. [back]

46. Scottish Intercollegiate Guidelines Network (SIGN). Mangement of obesity in children and young people. Edinburgh;SIGN:2003.(SIGN publication no.69) [back] [section 3.4] [section 5.1.1]

47. Odame I, Reilly JJ, Gibson BE, Donaldson MD. Patterns of obesity in boys and girls after treatment for acute lymphoblastic leukaemia. Arch Dis Child 1994;71(2):147-9. [back]

48. Craig F, Leiper AD, Stanhope R, Brain C, Heller ST, Nussey SS. Sexually dimorphic and radiation dose dependent effect of cranial irradiation on body mass index. Arch Dis Child 1999;81(6):500-4. [back]

49. Oeffinger KC, Mertens AC, Sklar CA, Yasui Y, Fears T, Stovall M, et al. Obesity in adult survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. J Clin Oncol 2003;21(7):1359-65. [back]

50. Burns EC, Tanner JM, Preece MA, Cameron N. Growth hormone treatment in children with craniopharyngioma: final growth status. Clin Endocrinol (Oxf) 1981;14(6):587-95. [back]

51. Butenandt O, Jocham A, Schwarz HP, Sperlich M, Tschop M. Childhood onset of GH deficiency: reassessment of GH status and effects of substitution. Growth Horm IGF Res 1998;8 Suppl A:9-13. [back]

52. Clayton PE, Shalet SM, Price DA. Growth response to growth hormone therapy following craniospinal irradiation. Eur J Pediatr 1988;147:597-601. [back] [section 3.5.1] [section 3.5.2]

53. Hovi L, Saarinen-Pihkala UM, Vettenranta K, Lipsanen M, Tapanainen P. Growth in children with poor-risk neuroblastoma after regimens with or without total body irradiation in preparation for autologous bone marrow transplantation. Bone Marrow Transplant 1999;24:1131-6. [back]

54. Hogeveen M, Noordam C, Otten B, Wit JM, Massa G. Growth before and during growth hormone treatment in children operated for craniopharyngioma. Horm Res 1997;48:258-62. [back]

55. Ogilvy-Stuart AL, Shalet SM. Growth and puberty after growth hormone treatment after irradiation for brain tumours. Arch Dis Child 1995;73(2):141-6. [back]

56. Ogilvy-Stuart AL, Stirling HF, Kelnar CJ, Savage MO, Dunger DB, Buckler JM, et al. Treatment of radiation-induced growth hormone deficiency with growth hormone-releasing hormone. Clin Endocrinol (Oxf) 1997;46(5):571-8. [back]

57. Sulmont V, Brauner R, Fontoura M, Rappaport R. Response to growth hormone treatment and final height after cranial or craniospinal irradiation. Acta Paediatr Scand 1990;79(5):542-9. [back]

58. Vassilopoulou-Sellin R, Klein MJ, Moore IB, Reid HL, Ater J, Zietz HA. Efficacy of growth hormone replacement therapy in children with organic growth hormone deficiency after cranial irradiation. Horm Res 1995;43:188-93. [back]

59. Winter RJ, Green OC. Irradiation-induced growth hormone deficiency: blunted growth response and accelerated skeletal maturation to growth hormone therapy. J Pediatr 1985;106(4):609-12. [back]

60. Papadimitriou A, Urena M, Hamill G, Stanhope R, Leiper AD. Growth hormone treatment of growth failure secondary to total body irradiation and bone marrow transplantation. Arch Dis Child 1991;66(6):689-92. [back]

61. Price DA, Ranke MB, Guilbaud O. Growth response in the first year of growth hormone treatment in prepubertal children with organic growth hormone deficiency: a comparison with idiopathic growth hormone deficiency. The Executive Scientific Committee of the Kabi International Growth Study. Acta Paediatr Scand - Supplement 1990;370:131-7,discussion 8. [back]

62. Price DA, Wilton P, Jonsson P, Albertsson-Wikland K, Chatelain P, Cutfield W, et al. Efficacy and safety of growth hormone treatment in children with prior craniopharyngioma: an analysis of the Pharmacia and Upjohn International Growth Database (KIGS) from 1988 to 1996. Horm Res 1998;49:91-7. [back] [section 3.5.1] [section 3.5.2]

63. Buchanan CR, Preece MA, Milner RD. Mortality, neoplasia, and Creutzfeldt-Jakob disease in patients treated with human pituitary growth hormone in the United Kingdom. BMJ 1991;302(6780):824-8. [back]

64. Clayton PE, Shalet SM, Gattamaneni HR, Price DA. Does growth hormone cause relapse of brain tumours? Lancet 1987;1(8535):711-3. [back]

65. Arslanian SA, Becker DJ, Lee PA, Drash AL, Foley TP, Jr. Growth hormone therapy and tumor recurrence. Findings in children with brain neoplasms and hypopituitarism. Am J Dis Child 1985;139(4):347-50. [back]

66. Sklar CA, Mertens AC, Mitby P, Occhiogrosso G, Qin J, Heller G, et al. Risk of disease recurrence and second neoplasms in survivors of childhood cancer treated with growth hormone: a report from the Childhood Cancer Survivor Study. J Clin Endocrinol Metab 2002;87(7):3136-41. [back]

67. Wyatt D. Melanocytic nevi in children treated with growth hormone. Pediatrics 1999;104(4 Pt 2):1045-50. [back]

68. Zvulunov A, Wyatt DT, Laud PW, Esterly NB. Lack of effect of growth hormone therapy on the count and density of melanocytic naevi in children. Br J Dermatol 1997;137(4):545-8. [back]

69. Fradkin JE, Mills JL, Schonberger LB, Wysowski DK, Thomson R, Durako SJ, et al. Risk of leukemia after treatment with pituitary growth hormone. JAMA 1993;270(23):2829-32. [back]

70. Pajari U, Lanning M. Developmental defects of teeth in survivors of childhood ALL are related to the therapy and age at diagnosis. Med Pediatr Oncol 1995;24:310-4. [back]

71. Kaste SC, Hopkins KP, Jones D, Crom D, Greenwald CA, Santana VM. Dental abnormalities in children treated for acute lymphoblastic leukemia. Leukemia 1997;11:792-6. [back]

72. Jaffe N, Toth BB, Hoar RE, Ried HL, Sullivan MP, McNeese MD. Dental and maxillofacial abnormalities in long-term survivors of childhood cancer: effects of treatment with chemotherapy and radiation to the head and neck. Pediatrics 1984;73:816-23. [back]

73. Kaste SC, Hopkins KP, Bowman LC. Dental abnormalities in long-term survivors of head and neck rhabdomyosarcoma. Med Pediatr Oncol 1995;25(2):96-101. [back]

74. Purdell-Lewis DJ, Stalman MS, Leeuw JA, Humphrey GB, Kalsbeek H. Long term results of chemotherapy on the developing dentition: caries risk and developmental aspects. Community Dent Oral Epidemiol 1988;16:68-71. [back]

75. Fromm M, Littman P, Raney RB, Nelson L, Handler S, Diamond G, et al. Late effects after treatment of twenty children with soft tissue sarcomas of the head and neck. Experience at a single institution with a review of the literature. Cancer 1986;57:2070-6. [back]

76. Nasman M, Forsberg CM, Dahllof G. Long-term dental development in children after treatment for malignant disease. Eur J Orthod 1997;19:151-9. [back]

77. Nasman M, Bjork O, Soderhall S, Ringden O, Dahllof G. Disturbances in the oral cavity in pediatric long-term survivors after different forms of antineoplastic therapy. Pediatr Dent 1994;16:217-23. [back]

78. Imhof SM, Mourits MP, Hofman P, Zonneveld FW, Schipper J, Moll AC, et al. Quantification of orbital and mid-facial growth retardation after megavoltage external beam irradiation in children with retinoblastoma. Ophthalmology 1996;103(2):263-8. [back]

79. Dahllof G, Forsberg CM, Ringden O, Bolme P, Borgstrom B, Nasman M, et al. Facial growth and morphology in long-term survivors after bone marrow transplantation. Eur J Orthod 1989;11:332-40. [back]

80. Dahllof G, Krekmanova L, Kopp S, Borgstrom B, Forsberg CM, Ringden O. Craniomandibular dysfunction in children treated with total-body irradiation and bone marrow transplantation. Acta Odontol Scand 1994;52:99-105. [back]

81. Guyuron B, Dagys AP, Munro IR, Ross RB. Effect of irradiation on facial growth: a 7- to 25-year follow-up. Ann Plast Surg 1983;11:423-7. [back]

82. Sonis AL, Waber DP, Sallan S, Tarbell NJ. The oral health of long-term survivors of acute lymphoblastic leukaemia: A comparison of three treatment modalities. Eur J Cancer B Oral Oncol 1995;31B:250-2. [back]

83. Fleming P, Kinirons MJ. Study of the dental health of children in remission from acute lymphoblastic leukaemia in Northern Ireland. Community Dent Oral Epidemiol 1993;21:309-12. [back]

84. Dens F, Boute P, Otten J, Vinckier F, Declerck D. Dental caries, gingival health, and oral hygiene of long term survivors of paediatric malignant diseases. Arch Dis Child 1995;72:129-32. [back]

85. Duggal MS, Curzon ME, Bailey CC, Lewis IJ, Prendergast M. Dental parameters in the long-term survivors of childhood cancer compared with siblings. Oral Oncol 1997;33:348-53. [back]

86. Dens F, Boogaerts M, Boute P, Declerck D, Demuynck H, Vinckier F, et al. Caries-related salivary microorganisms and salivary flow rate in bone marrow recipients. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, & Endodontics 1996;81:38-43. [back]

87. Clinical guideline on the dental management of pediatric patients receiving chemotherapy, bone marrow transplantation and/or radiation. American Academy of Pediatric Dentistry. Pediatr Dent 2001;23:82-4. [back]

88. Multidisciplinary Working Group convened by the British Fertility Society. A strategy for fertility services for survivors of childhood cancer. Hum Fertil (Camb) 2003;6(2):A1-A40. [back]

89. Nielsen CT, Skakkebaek NE, Richardson DW, Darling JA, Hunter WM, Jorgensen M, et al. Onset of the release of spermatozoa (spermarche) in boys in relation to age, testicular growth, pubic hair, and height. J Clin Endocrinol Metab 1986;62(3):532-5. [back]

90. Lahteenmaki PM, Toppari J, Ruokonen A, Laitinen P, Salmi TT. Low serum inhibin B concentrations in male survivors of childhood malignancy. Eur J Cancer 1999;35(4):612-9. [back]

91. Muller HL, Klinkhammer-Schalke M, Seelbach-Gobel B, Hartmann AA, Kuhl J. Gonadal function of young adults after therapy of malignancies during childhood or adolescence. Eur J Pediatr 1996;155(9):763-9. [back][section 4.1.2] [section 4.2.3]

92. Papadakis V, Vlachopapadopoulou E, Van Syckle K, Ganshaw L, Kalmanti M, Tan C, et al. Gonadal function in young patients successfully treated for Hodgkin disease. Med Pediatr Oncol 1999;32(5):366-72. [back]

93. Siimes MA, Rautonen J. Small testicles with impaired production of sperm in adult male survivors of childhood malignancies. Cancer 1990;65(6):1303-6. [back]

94. Ahmed SR, Shalet SM, Campbell RH, Deakin DP. Primary gonadal damage following treatment of brain tumors in childhood. J Pediatr 1983;103(4):562-5. [back]

95. Blatt J, Poplack DG, Sherins RJ. Testicular function in boys after chemotherapy for acute lymphoblastic leukemia. N Engl J Med 1981;304(19):1121-4. [back]

96. Mayer EI, Dopfer RE, Klingebiel T, Scheel-Walter H, Ranke MB, Niethammer D. Longitudinal gonadal function after bone marrow transplantation for acute lymphoblastic leukemia during childhood. Pediatr Transplant 1999;3(1):38-44. [back]

97. Kobayashi H, Urashima M, Hoshi Y, Uchiyama H, Fujisawa K, Akatsuka J, et al. Testicular morphological changes in children with acute lymphoblastic leukemia following chemotherapy. Acta Paediatr Jpn 1996;38(6):640-3. [back]

98. Ogilvy-Stuart AL, Clark DJ, Wallace WH, Gibson BE, Stevens RF, Shalet SM, et al. Endocrine deficit after fractionated total body irradiation. Arch Dis Child 1992;67(9):1107-10. [back] [section 4.1.2] [section 4.2.3]

99. Wallace WH, Shalet SM, Lendon M, Morris-Jones PH. Male fertility in long-term survivors of childhood acute lymphoblastic leukaemia. Int J Androl 1991;14(5):312-9. [back]

100. Ortin TT, Shostak CA, Donaldson SS. Gonadal status and reproductive function following treatment for Hodgkin’s disease in childhood: the Stanford experience . Int J Radiat Oncol Biol Phys 1990;19(4):873-80. [back] [section 4.1.2] [section 4.1.4] [section 4.2.3] [section 4.2.4]

101. Lannering B, Jansson C, Rosberg S, Albertsson-Wikland K. Increased LH and FSH secretion after cranial irradiation in boys. Med Pediatr Oncol 1997;29(4):280-7. [back]

102. Green DM, Brecher ML. Gonadal function in pediatric patients following treatment for Hodgkin disease. Med Pediatr Oncol 1981;9(3):235-44. [back] [section 4.1.2] [section 4.2.4]

103. Sanders JE, Buckner CD, Leonard JM, Sullivan KM, Witherspoon RP, Deeg HJ, et al. Late effects on gonadal function of cyclophosphamide, total-body irradiation, and marrow transplantation. Transplantation 1983;36(3):252-5. [back] [section 4.1.2] [section 4.2.3]

104. Whitehead E, Shalet SM, Jones PH, Beardwell CG, Deakin DP. Gonadal function after combination chemotherapy for Hodgkin’s disease in childhood. Arch Dis Child 1982;57(4):287-91. [back] [section 4.1.2] [section 4.2.3]

105. Shalet SM, Hann IM, Lendon M, Morris Jones PH, Beardwell CG. Testicular function after combination chemotherapy in childhood for acute lymphoblastic leukaemia. Arch Dis Child 1981;56(4):275-8. [back]

106. Grundy RG, Leiper AD, Stanhope R, Chessells JM. Survival and endocrine outcome after testicular relapse in acute lymphoblastic leukaemia. Arch Dis Child 1997;76(3):190-6. [back]

107. Aubier F, Flamant F, Brauner R, Caillaud JM, Chaussain JM, Lemerle J. Male gonadal function after chemotherapy for solid tumors in childhood. J Clin Oncol 1989;7(3):304-9. [back]

108. Heikens J, Behrendt H, Adriaanse R, Berghout A. Irreversible gonadal damage in male survivors of pediatric Hodgkin’s disease. Cancer 1996;78(9):2020-4. [back]

109. Dhabhar BN, Malhotra H, Joseph R, Garde S, Bhasin S, Sheth A, et al. Gonadal function in prepubertal boys following treatment for Hodgkin’s disease. Am J Pediatr Hematol Oncol 1993;15(3):306-10. [back]

110. Siimes MA, Rautonen J, Makipernaa A, Sipila I. Testicular function in adult males surviving childhood malignancy. Pediatr Hematol Oncol 1995;12(3):231-41. [back]

111. Shalet SM, Horner A, Ahmed SR, Morris-Jones PH. Leydig cell damage after testicular irradiation for lymphoblastic leukaemia. Med Pediatr Oncol 1985;13(2):65-8. [back]

112. Sklar CA, Robison LL, Nesbit ME, Sather HN, Meadows AT, Ortega JA, et al. Effects of radiation on testicular function in long-term survivors of childhood acute lymphoblastic leukemia: a report from the Children Cancer Study Group. J Clin Oncol 1990;8:1981-7. [back]

113. Leiper AD, Grant DB, Chessells JM. Gonadal function after testicular radiation for acute lymphoblastic leukaemia. Arch Dis Child 1986;61(1):53-6. [back]

114. Sarafoglou K, Boulad F, Gillio A, Sklar C. Gonadal function after bone marrow transplantation for acute leukemia during childhood. J Pediatr 1997;130(2):210-6. [back] [section 4.1.2] [section 4.2.3]

115. Thomson AB, Campbell AJ, Irvine DC, Anderson RA, Kelnar CJ, Wallace WH. Semen quality and spermatozoal DNA integrity in survivors of childhood cancer: a case-control study. Lancet 2002;360(9330):361-7. [back]

116. Mackie EJ, Radford M, Shalet SM. Gonadal function following chemotherapy for childhood Hodgkin’s disease. Med Pediatr Oncol 1996;27(2):74-8. [back] [section 4.1.2] [section 4.2.3]

117. Bramswig JH, Heimes U, Heiermann E, Schlegel W, Nieschlag E, Schellong G. The effects of different cumulative doses of chemotherapy on testicular function. Results in 75 patients treated for Hodgkin’s disease during childhood or adolescence. Cancer 1990;65(6):1298-302. [back]

118. Livesey EA, Brook CG. Gonadal dysfunction after treatment of intracranial tumours. Arch Dis Child 1988;63(5):495-500. [back]

119. Kulkarni SS, Sastry PS, Saikia TK, Parikh PM, Gopal R, Advani SH. Gonadal function following ABVD therapyfor Hodgkin’s disease. Am J Clin Oncol 1997;20(4):354-7. [back]

120. Viviani S, Santoro A, Ragni G, Bonfante V, Bestetti O, Bonadonna G. Gonadal toxicity after combination chemotherapy for Hodgkin’s disease. Comparative results of MOPP vs ABVD. Eur J Cancer Clin Oncol 1985;21:601-5. [back]

121. Kliesch S, Behre HM, Jurgens H, Nieschlag E. Cryopreservation of semen from adolescent patients with malignancies . Med Pediatr Oncol 1996;26(1):20-7. [back]

122. Muller J, Sonksen J, Sommer P, Schmiegelow M, Petersen PM, Heilman C, et al. Cryopreservation of semen from pubertal boys with cancer. Med Pediatr Oncol 2000;34(3):191-4. [back]

123. Lass A, Akagbosu F, Abusheikha N, Hassouneh M, Blayney M, Avery S, et al. A programme of semen cryopreservation for patients with malignant disease in a tertiary infertility centre: lessons from 8 years’ experience. Hum Reprod 1998;13(11):3256-61. [back]

124. Byrne J, Mulvihill JJ, Connelly RR, Austin DA, Holmes GE, Holmes FF, et al. Reproductive problems and birth defects in survivors of Wilms’ tumor and their relatives. Med Pediatr Oncol 1988;16(4):233-40. [back] [section 4.1.2] [section 4.2.3] [section 4.2.4]

125. Li FP, Fine W, Jaffe N, Holmes GE, Holmes FF. Offspring of patients treated for cancer in childhood. J Natl Cancer Inst 1979;62(5):1193-7. [back] [section 4.1.4] [section 4.2.4]

126. Baker TG. A quantitative and cytological study of germ cells in human ovaries. Proc R Soc London B Biol Sci 1999;158:417-33. [back]

127. Marshall WA, Tanner JM. Variations in pattern of pubertal changes in girls. Arch Dis Child 1969;44(235):291-303. [back]

128. Quigley C, Cowell C, Jimenez M, Burger H, Kirk J, Bergin M, et al. Normal or early development of puberty despite gonadal damage in children treated for acute lymphoblastic leukemia . N Engl J Med 1989;321(3):143-51. [back]

129. Holm K, Nysom K, Brocks V, Hertz H, Jacobsen N, Muller J. Ultrasound B-mode changes in the uterus and ovaries and Doppler changes in the uterus after total body irradiation and allogeneic bone marrow transplantation in childhood. Bone Marrow Transplant 1999;23(3):259-63. [back]

130. Teinturier C, Hartmann O, Valteau-Couanet D, Benhamou E, Bougneres PF. Ovarian function after autologous bone marrow transplantation in childhood: high-dose busulfan is amajor cause of ovarian failure. Bone Marrow Transplant 1998;22(10):989-94. [back]

131. Sanders JE, Pritchard S, Mahoney P, Amos D, Buckner CD, Witherspoon RP, et al. Growth and development following marrow transplantation for leukemia. Blood 1986;68(5):1129-35. [back]

132. Sanders JE, Hawley J, Levy W, Gooley T, Buckner CD, Deeg HJ, et al. Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood 1996;87(7):3045-52. [back]

133. Wallace WH, Thomson AB, Kelsey TW. The radiosensitivity of the human oocyte. Hum Reprod 2003;18(1):117-21. [back]

134. Critchley HO, Wallace WH, Shalet SM, Mamtora H, Higginson J, Anderson DC. Abdominal irradiation in childhood;the potential for pregnancy. Br J Obstet Gynaecol 1992;99(5):392-4. [back]

135. Bath LE, Critchley HO, Chambers SE, Anderson RA, Kelnar CJ, Wallace WH. Ovarian and uterine characteristics after total body irradiation in childhood and adolescence: response to sex steroid replacement. Br J Obstet Gynaecol 1999;106(12):1265-72. [back]

136. Wallace WH, Shalet SM, Tetlow LJ, Morris-Jones PH. Ovarian function following the treatment of childhood acute lymphoblastic leukaemia. Med Pediatr Oncol 1993;21(5):333-9. [back]

137. Green DM, Yakar D, Brecher ML, Lindsay AN, Voorhess ML, MacGillivray MH. Ovarian function in adolescent women following successful treatment for non-Hodgkin’s lymphoma. Am J Pediatr Hematol Oncol 1983;5(1):27-31. [back]

138. Bath LE, Anderson RA, Critchley HO, Kelnar CJ, Wallace WH. Hypothalamic-pituitary-ovarian dysfunction after prepubertal chemotherapy and cranial irradiation for acute leukaemia. Hum Reprod 2001;16(9):1838-44. [back] [section 4.2.3] [section 4.2.4]

139. Chiarelli AM, Marrett LD, Darlington G. Early menopause and infertility in females after treatment for childhood cancer diagnosed in 1964-1988 in Ontario, Canada. Am J Epidemiol 1999;150(3):245-54. [back]

140. Green DM, Peabody EM, Nan B, Peterson S, Kalapurakal JA, Breslow NE. Pregnancy outcome after treatment for Wilms tumor: a report from the National Wilms Tumor Study Group. J Clin Oncol 2002;20(10):2506-13. [back]

141. Hawkins MM, Smith RA. Pregnancy outcomes in childhood cancer survivors: probable effects of abdominal irradiation. Int J Cancer 1989;43(3):399-402. [back]

142. Green DM, Whitton JA, Stovall M, Mertens AC, Donaldson SS, Ruymann FB, et al. Pregnancy outcome of female survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Am J Obstet Gynecol 2002;187(4):1070-80. [back]

143. Nygaard R, Clausen N, Siimes MA, Marky I, Skjeldestad FE, Kristinsson JR, et al. Reproduction following treatment for childhood leukemia: a population-based prospective cohort study of fertility and offspring. Med Pediatr Oncol 1991;19(6):459-66. [back]

144. Wallace WH, Shalet SM, Crowne EC, Morris-Jones PH, Gattamaneni HR. Ovarian failure following abdominal irradiation in childhood: natural history and prognosis. Clin Oncol (R Coll Radiol) 1989;1(2):75-9. [back]

145. van Leeuwen FE, Klokman WJ, Stovall M, Dahler EC, van’t Veer MB, Noordijk EM, et al. Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin’s disease. J Natl Cancer Inst 2003;95(13):971-80. [back]

146. Travis LB, Hill DA, Dores GM, Gospodarowicz M, van Leeuwen FE, Holowaty E, et al. Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease. JAMA 2003;290(4):465-75. Erratum in: JAMA. 2003 Sep 10;290(10):1318. [back]

147. Swerdlow AJ, Barber JA, Hudson GV, Cunningham D, Gupta RK, Hancock BW, et al. Risk of second malignancy after Hodgkin’s disease in a collaborative British cohort: the relation to age at treatment. J Clin Oncol 2000;18(3):498-509. [back]

148. Boivin JF, Hutchison GB, Lubin JH, Mauch P. Coronary artery disease mortality in patients treated for Hodgkin’s disease. Cancer 1992;69:1241-7. [back] [section 5.1] [section 5.1.1]

149. Hancock SL, Tucker MA, Hoppe RT. Factors affecting late mortality from heart disease after treatment of Hodgkin’s disease. JAMA 1993;270:1949-55. [back] [section 5.1] [section 5.1.1]

150. Ewer MS, Jaffe N, Ried H, Zietz HA, Benjamin RS. Doxorubicin cardiotoxicity in children: Comparison of a consecutive divided daily dose administration schedule with single dose (rapid) infusion administration. Med Pediatr Oncol 1998;31:512-5. [back]

151. Green DM, Gingell RL, Pearce J, Panahon AM, Ghoorah J. The effect of mediastinal irradiation on cardiac function of patients treated during childhood and adolescence for Hodgkin’s disease. J Clin Oncol 1987;5:239-45. [back] [section 5.1] [section 5.1.1]

152. Hancock SL, Donaldson SS, Hoppe RT. Cardiac disease following treatment of Hodgkin’s disease in children and adolescents . J Clin Oncol 1993;11:1208-15. [back] [section 5.1] [section 5.1.1]

153. Heikens J, Ubbink MC, van der Pal HP, Bakker PJ, Fliers E, Smilde TJ, et al. Long term survivors of childhood brain cancer have an increased risk for cardiovascular disease. Cancer 2000;88:2116-21. [back] [section 5.1] [section 5.1.1]

154. Ilhan I, Sarialioglu F, Ozbarlas N, Buyukpamukcu M, Akyuz C, Kutluk T. Late cardiac effects after treatment for childhood Hodgkin’s disease with chemotherapy and low-dose radiotherapy. Postgrad Med J 1995;71:164-7. [back] [section 5.1] [section 5.1.1]

155. Johnson GL, Moffett CB, Geil JD, Greenwood MF, Noonan JA. Late echocardiographic findings following childhood chemotherapy with normal serial cardiac monitoring. J Pediatr Hematol Oncol 1996;18:72-5. [back] [section 5.1] [section 5.1.1]

156. King V, Constine LS, Clark D, Schwartz RG, Muhs AG, Henzler M, et al. Symptomatic coronary artery disease after mantle irradiation for Hodgkin’s disease . Int J Radiat Oncol Biol Phys 1996;36:881-9. [back] [section 5.1] [section 5.1.1]

157. Klewer SE, Goldberg SJ, Donnerstein RL, Berg RA, Hutter JJ, Jr. Dobutamine stress echocardiography: a sensitive indicator of diminished myocardial function in asymptomatic doxorubicin-treated long-term survivors of childhood cancer. J Am Coll Cardiol 1992;19:394-401. [back]

158. Parsons SK, Skapek SX, Neufeld EJ, Kuhlman C, Young ML, Donnelly M, et al. Asparaginase-associated lipid abnormalities in children with acute lymphoblastic leukemia. Blood 1997;89:1886-95. [back]

159. Postma A, Bink-Boelkens MT, Beaufort-Krol GC, Kengen RA, Elzenga NJ, Schasfoort-van Leeuwen MJ, et al. Late cardiotoxicity after treatment for a malignant bone tumor. Med Pediatr Oncol 1996;26:230-7. [back]

160. Reinders JG, Heijmen BJ, Olofsen-van Acht MJ, van Putten WL, Levendag PC. Ischemic heart disease after mantlefield irradiation for Hodgkin’s disease in long-term follow-up. Radiother Oncol 1999;51:35-42. [back] [section 5.1] [section 5.1.1]

161. De Wolf D, Suys B, Maurus R, Benoit Y, Verhaaren H, Matthijs D, et al. Dobutamine stress echocardiography in the evaluation of late anthracycline cardiotoxicity in childhood cancer survivors. Pediatr Res 1996;39:504-12. [back]

162. Black P, Gutjahr P, Stopfkuchen H. Physical performance in long-term survivors of acute leukaemia in childhood. Eur J Pediatr 1998;157:464-7. [back]

163. Bu’Lock FA, Mott MG, Oakhill A, Martin RP. Left ventricular diastolic function after anthracycline chemotherapy in childhood: relation with systolic function, symptoms, and pathophysiology. Br Heart J 1995;73:340-50. [back] [section 5.1] [section 5.2]

164. Bu’Lock FA, Mott MG, Oakhill A, Martin RP. Early identification of anthracycline cardiomyopathy: possibilities and implications. Arch Dis Child 1996;75:416-22. [back] [section 5.1] [section 5.2]

165. Kakadekar AP, Sandor GG, Fryer C, Chan KW, Rogers PC, Pritchard S, et al. Differences in dose scheduling as a factor in the etiology of anthracycline-induced cardiotoxicity in Ewing sarcoma patients. Med Pediatr Oncol 1997;28:22-6. [back]

166. Kremer LC, Tiel-van Buul MM, Ubbink MC, Offringa M, Ottenkamp J, Olmos RV, et al. Indium-111-antimyosin scintigraphy in the early detection of heart damage after anthracycline therapy in children. J Clin Oncol 1999;17:1208-11. [back]

167. Rammeloo LA, Postma A, Sobotka-Plojhar MA, Bink-Boelkens MT, Berg A, Veerman AJ, et al. Low-dose daunorubicin in induction treatment of childhood acute lymphoblastic leukemia: no long-term cardiac damage in a randomized study of the Dutch childhood leukemia study group. Med Pediatr Oncol 2000;35:13-9. [back]

168. Lanzarini L, Bossi G, Laudisa ML, Klersy C, Arico M. Lack of clinically significant cardiac dysfunction during intermediate dobutamine doses in long-term childhood cancer survivors exposed to anthracyclines. Am Heart J 2000;140:315-23. [back]

169. Li CK, Sung RY, Kwok KL, Leung TF, Shing MM, Chik KW, et al. A longitudinal study of cardiac function in children with cancer over 40 months. Pediatr Hematol Oncol 2000;17:77-83. [back]

170. Lenk MK, Zeybek C, Okutan V, Ozcan O, Gokcay E. Detection of early anthracycline-induced cardiotoxicity in childhood cancer with dobutamine stress echocardiography. Turk J Pediatr 1998;40:373-83. [back]

171. Lipshultz SE, Lipsitz SR, Mone SM, Goorin AM, Sallan SE, Sanders SP, et al. Female sex and drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer . N Engl J Med 1995;332(26):1738-43. [back] [section 5.1] [section 5.2]

172. Mladosievicova B, Foltinova A, Petrasova H, Hulin I. Late effects of anthracycline therapy in childhood on signal-averaged ECG parameters. Int J Mol Med 2000;5:411-4. [back] [section 5.1] [section 5.2]

173. Musci M, Loebe M, Grauhan O, Weng Y, Hummel M, Lange P, et al. Heart transplantation for doxorubicin-induced congestive heartfailure in children and adolescents. Transplant Proc 1997;29(1-2):578-9. [back]

174. Pihkala J, Saarinen UM, Lundstrom U, Virtanen K, Virkola K, Siimes MA, et al. Myocardial function in children and adolescents after therapy with anthracyclines and chest irradiation. Eur J Cancer 1996;32A:97-103. [back] [section 5.1] [section 5.1.1]

175. Schwartz CL, Hobbie WL, Truesdell S, Constine LC, Clark EB. Corrected QT interval prolongation in anthracycline-treated survivors of childhood cancer. J Clin Oncol 1993;11:1906-10. [back]

176. Sorensen K, Levitt G, Sebag-Montefiore D, Bull C, Sullivan I. Cardiac function in Wilms’ tumor survivors. J Clin Oncol 1995;13:1546-56. [back]

177. Sorensen K, Levitt G, Bull C, Chessells J, Sullivan I. Anthracycline dose in childhood acute lymphoblastic leukemia: issues of early survival versus late cardiotoxicity. J Clin Oncol 1997;15:61-8. [back]

178. Sung RY, Huang GY, Shing MK, Oppenheimer SJ, Li CK, Lau J, et al. Echocardiographic evaluation of cardiac function in paediatric oncology patients treated with or without anthracycline. Int J Cardiol 1997;60:239-48. [back]

179. Zalewska-Szewczyk B, Lipiec J, Bodalski J. Late cardiotoxicity of anthracyclines in children with acute leukemia. Klin Padiatr 1999;211:356-9. [back]

180. Steinherz LJ, Steinherz PG, Tan C. Cardiac failure and dysrhythmias 6-19 years after anthracycline therapy: a series of 15 patients. Med Pediatr Oncol 1995;24(6):352-61. [back]

181. Bigras JL, Fournier A, McCrindle BW, Cartwright D, Davignon A, Leclerc JM. Functional cardiac disturbances related to chemotherapy independent of anthracycline use in children with neoplastic disease. Am J Cardiol 1995;75:101-3. [back]

182. Kremer LC, van Dalen EC, Offringa M, Voute PA. Frequency and risk factors of anthracycline-induced clinical heart failure in children:a systematic review. Ann Oncol 2002;13(4):503-12. [back]

183. Ungerleider RS, Pratt CB, Vietti TJ, Holcenberg JS, Kamen BA, Glaubiger DL, et al. Phase I trial of mitoxantrone in children. Cancer Treat Rep 1985;69(4):403-7. [back]

184. Aviles A, Arevila N, Diaz Maqueo JC, Gomez T, Garcia R, Nambo MJ. Late cardiac toxicity of doxorubicin, epirubicin, and mitoxantrone therapy for Hodgkin’s disease in adults. Leuk Lymphoma 1993;11(3-4):275-9. [back]

185. Weiss RB, Grillo-Lopez AJ, Marsoni S, Posada JG, Hess F, Ross BJ. Amsacrine-associated cardiotoxicity:an analysis of 82 cases. J Clin Oncol 1986;4(6):918-28. [back]

186. Wexler LH, Andrich MP, Venzon D, Berg SL, Weaver-McClure L, Chen CC, et al. Randomized trial of the cardioprotective agent ICRF-187 in pediatric sarcoma patients treated with doxorubicin. J Clin Oncol 1996;14(2):362-72. [back]

187. Lipshultz SE, Giantris AL, Lipsitz SR, Kimball Dalton V, Asselin BL, Barr RD, et al. Doxorubicin administration by continuous infusion is not cardioprotective: the Dana-Farber 91-01 Acute Lymphoblastic Leukemia protocol. J Clin Oncol 2002;20(6):1677-82. [back]

188. Sorensen K, Levitt GA, Bull C, Dorup I, Sullivan ID. Late anthracycline cardiotoxicity after childhood cancer: a prospective longitudinal study. Cancer 2003;97(8):1991-8. [back]

189. Jensen BV, Skovsgaard T, Nielsen SL. Functional monitoring of anthracycline cardiotoxicity: a prospective, blinded, long-term observational study of outcome in 120 patients. Ann Oncol 2002;13(5):699-709. [back]

190. Jensen BV, Nielsen SL, Skovsgaard T. Treatment with angiotensin-converting-enzyme inhibitor for epirubicin-induced dilated cardiomyopathy. Lancet 1996;347(8997):297-9. [back]

191. Silber JH, Cnaan A, Clark BJ, Paridon SM, Chin AJ, Rychik J, et al. Design and baseline characteristics for the ACE Inhibitor After Anthracycline (AAA) study of cardiac dysfunction in long-term pediatric cancer survivors. Am Heart J 2001;142(4):577-85. [back]

192. Lipshultz SE, Lipsitz SR, Sallan SE, Simbre VC, Shaikh SL, Mone SM, et al. Long-term enalapril therapy for left ventricular dysfunction in doxorubicin-treated survivors of childhood cancer. J Clin Oncol 2002;20(23):4517-22. [back]

193. Sklar C, Whitton J, Mertens A, Stovall M, Green D, Marina N, et al. Abnormalities of the thyroid in survivors of Hodgkin’s disease: data from the Childhood Cancer Survivor Study. J Clin Endocrinol Metab 2000;85(9):3227-32. [back]

194. Picco P, Garaventa A, Claudiani F, Gattorno M, De Bernardi B, Borrone C. Primary hypothyroidism as a consequence of 131-I-metaiodobenzylguanidine treatment for children with neuroblastoma. Cancer 1995;76:1662-4. [back]

195. Devney RB, Sklar CA, Nesbit ME, Jr., Kim TH, Williamson JF, Robison LL, et al. Serial thyroid function measurements in children with Hodgkin disease. J Pediatr 1984;105:223-7. [back]

196. Fleming ID, Black TL, Thompson EI, Pratt C, Rao B, Hustu O. Thyroid dysfunction and neoplasia in children receiving neck irradiation for cancer. Cancer 1985;55:1190-4. [back]

197. Green DM, Brecher ML, et al. Thyroid function in pediatric patients after neck irradiation for Hodgkin disease. Med Pediatr Oncol 1980;8:127-36. [back]

198. Black P, Straaten A, Gutjahr P. Secondary thyroid carcinoma after treatment for childhood cancer. Med Pediatr Oncol 1998;31:91-5. [back]

199. Tucker MA, Jones PH, Boice JD Jr, Robison LL, Stone BJ, Stovall M, et al. Therapeutic radiation at a young age is linked to secondary thyroid cancer. The Late Effects Study Group. Cancer Res 1991;51:2885-8. [back]

200. Chin D, Sklar C, Donahue B, Uli N, Geneiser N, Allen J, et al. Thyroid dysfunction as a late effect in survivors of pediatric medulloblastoma/primitive neuroectodermal tumors: a comparison of hyperfractionated versus conventional radiotherapy. Cancer 1997;80:798-804. [back]

201. Oberfield SE, Allen JC, Pollack J, New MI, Levine LS. Long-term endocrine sequelae after treatment of medulloblastoma: prospective study of growth and thyroid function. J Pediatr 1986;108(2):219-23. [back] [section 6.1.2] [section 6.1.5]

202. Pottern LM, Kaplan MM, Larsen PR, Silva JE, Koenig RJ, Lubin JH, et al. Thyroid nodularity after childhood irradiation for lymphoid hyperplasia: a comparison of questionnaire and clinical findings. J Clin Epidemiol 1990;43:449-60. [back]

203. Favus MJ, Schneider AB, Stachura ME, Arnold JE, Ryo UY, Pinsky SM, et al. Thyroid cancer occurring as a late consequence of head-and-neck irradiation. Evaluation of 1056 patients. N Engl J Med 1976;294(19):1019-25. [back]

204. Borgstrom B, Bolme P. Thyroid function in children after allogeneic bone marrow transplantation. Bone Marrow Transplant 1994;13:59-64. [back]

205. Katsanis E, Shapiro RS, Robison LL, Haake RJ, Kim T, Pescovitz OH, et al. Thyroid dysfunction following bone marrow transplantation: long-term follow-up of 80 pediatric patients. Bone Marrow Transplant 1990;5:335-40. [back]

206. Thomas BC, Stanhope R, Plowman PN, Leiper AD. Endocrine function following single fraction and fractionated total body irradiation for bone marrow transplantation in childhood. Acta Endocrinol (Copenh) 1993;128(6):508-12. [back]

207. Livesey EA, Brook CG. Thyroid dysfunction after radiotherapy and chemotherapy of brain tumours. Arch Dis Child 1989;64(4):593-5. [back]

208. Shafford EA, Kingston JE, Healy JC, Webb JA, Plowman PN, Reznek RH. Thyroid nodular disease after radiotherapy to the neck for childhood Hodgkin’s disease. Br J Cancer 1999;80(5-6):808-14. [back]

209. Soberman N, Leonidas JC, Cherrick I, Schiff R, Karayalcin G. Sonographic abnormalities of the thyroid gland in longterm survivors of Hodgkin disease. Pediatr Radiol 1991;21(4):250-3. [back]

210. Solt I, Gaitini D, Pery M, Hochberg Z, Stein M, Arush MW. Comparing thyroid ultrasonography to thyroid function in long-term survivors of childhood lymphoma. Med Pediatr Oncol 2000;35(1):35-40. [back]

211. Brouwers P, Riccardi R, Poplack D, Fedio P. Attentional deficits in long-term survivors of childhood acute lymphoblastic leukemia (ALL). J Clin Neuropsychol 1984;6(3):325-36. [back]

212. Ciesielski KT, Yanofsky R, Ludwig RN, Hill DE, Hart BL, Astur RS, et al. Hypoplasia of the cerebellar vermis and cognitive deficits in survivors of childhood leukemia. Arch Neurol 1994;51(10):985-93. [back]

213. Abayomi O, Chun MS, Kelly K. Cerebral calcification and learning disabilities following cranial irradiation for medulloblastoma. J Natl Med Assoc 1990;82(12):833-6. [back]

214. Bakke SJ, Fossen A, Storm-Mathiesen I, Lie SO. Long-term cerebral effects of CNS chemotherapy in children with acute lymphoblastic leukemia. Pediatr Hematol Oncol 1993;10:267-70. [back]

215. Siffert J, Poussaint TY, Goumnerova LC, Scott RM, LaValley B, Tarbell NJ, et al. Neurological dysfunction associated with postoperative cerebellar mutism. J Neurooncol 2000;48:75-81. [back]

216. Laitt RD, Chambers EJ, Goddard PR, Wakeley CJ, Duncan AW, Foreman NK. Magnetic resonance imaging and magnetic resonance angiography in long term survivors of acute lymphoblastic leukemia treated with cranial irradiation. Cancer 1995;76(10):1846-52. [back]

217. Paakko E, Talvensaari K, Pyhtinen J, Lanning M. Late cranial MRI after cranial irradiation in survivors of childhood cancer. Neuroradiology 1994;36:652-5. [back]

218. Heukrodt C, Powazek M, Brown WS, Kennelly D, et al. Electrophysiological signs of neurocognitive deficits in long-term leukemia survivors. J Pediatr Psychol 1988;13:223-36. [back]

219. Russo A, Schiliro G. Some aspects of neurotoxicity associated with central nervous system prophylaxis in childhood leukemia. Acta Haematol 1987;78(Suppl 1):139-41. [back]

220. Mulhern RK, Reddick WE, Palmer SL, Glass JO, Elkin TD, Kun LE, et al. Neurocognitive deficits in medulloblastoma survivors and white matter loss. Ann Neurol 1999;46(6):834-41. [back]

221. Moore BDr, Ater JL, Copeland DR. Improved neuropsychological outcome in children with brain tumors diagnosed during infancy and treated without cranial irradiation. J Child Neurol 1992;7:281-90. [back]

222. Catsman-Berrevoets CE, Van Dongen HR, Mulder PG, Paz y Geuze D, Paquier PF, Lequin MH. Tumour type and size are high risk factors for the syndrome of ‘cerebellar’ mutism and subsequent dysarthria. J Neurol Neurosurg Psychiatry 1999;67(6):755-7. [back]

223. Harila-Saari AH, Paakko EL, Vainionpaa LK, Pyhtinen J, Lanning BM. A longitudinal magnetic resonance imaging study of the brain in survivors in childhood acute lymphoblastic leukemia. Cancer 1998;83(12):2608-17. [back]

224. Lamothe I, Robaey P, Precourt S, Kabene S, Moghrabi A. Psychophysiological evaluation of treatments on visual attention processes in young girls who survived to acute lymphoblastic leukemia. Brain Cogn 1998;37(1):152-5. [back]

225. Halberg FE, Kramer JH, Moore IM, Wara WM, Matthay KK, Ablin AR. Prophylactic cranial irradiation dose effects on late cognitive function in children treated for acute lymphoblastic leukemia. Int J Radiat Oncol Biol Phys 1992;22(1):13-6. [back]

226. Mulhern RK, Kovnar EH, Kun LE, Crisco JJ, Williams JM. Psychologic and neurologic function following treatment for childhood temporal lobe astrocytoma. J Child Neurol 1988;3:47-52. [back]

227. Syndikus I, Tait D, Ashley S, Jannoun L. Long-term follow-up of young children with brain tumors after irradiation. Int J Radiat Oncol Biol Phys 1994;30:781-7. [back]

228. Waber DP, Tarbell NJ, Kahn CM, Gelber RD, Sallan SE. The relationship of sex and treatment modality to neuropsychologic outcome in childhood acute lymphoblastic leukemia. J Clin Oncol 1992;10(5):810-7. [back]

229. Waber DP, Tarbell NJ, Fairclough D, Atmore K, Castro R, Isquith P, et al. Cognitive sequelae of treatment in childhood acute lymphoblastic leukemia: cranial radiation requires an accomplice. J Clin Oncol 1995;13(10):2490-6. [back]

230. Kingma A, Rammeloo LA, van Der Does-van den Berg A, Rekers-Mombarg L, Postma A. Academic career after treatment for acute lymphoblastic leukaemia. Arch Dis Child 2000;82(5):353-7. [back]

231. Said JA, Waters BG, Cousens P, Stevens MM. Neuropsychological sequelae of central nervous system prophylaxis in survivors of childhood acute lymphoblastic leukemia. J Consult Clin Psychol 1989;57(2):251-6. [back]

232. Tamaroff M, Miller DR, Murphy ML, Salwen R, Ghavimi F, Nir Y. Immediate and long-term posttherapy neuropsychologic performance in children with acute lymphoblastic leukemia treated without central nervous system radiation. J Pediatr 1982;101(4):524-9. [back]

233. MacLean WE, Noll RB, Stehbens JA, Kaleita TA, Schwartz E, Whitt JK, et al. Neuropsychological effects of cranial irradiation in young children with acute lymphoblastic leukemia 9 months after diagnosis. The Children’s Cancer Group. Arch Neurol 1995;52(2):156-60. [back]

234. Jankovic M, Brouwers P, Valsecchi MG, Van Veldhuizen A, Huisman J, Kamphuis R, et al. Association of 1800 cGy cranial irradiation with intellectual function in children with acute lymphoblastic leukaemia. ISPACC. International Study Group on Psychosocial Aspects of Childhood Cancer. Lancet 1994;344(8917):224-7. [back]

235. Ch’ien LT, Aur RJ, Stagner S, Cavallo K, Wood A, Goff J, et al. Long-term neurological implications of somnolence syndrome in children with acute lymphocytic leukemia. Ann Neurol 1980;8(3):273-7. [back]

236. Dennis M, Spiegler BJ, Hetherington CR, Greenberg ML. Neuropsychological sequelae of the treatment of children with medulloblastoma. J Neurooncol 1996;29:91-101. [back]

237. Mulhern RK, Ochs J, Fairclough D. Deterioration of intellect among children surviving leukemia: IQ test changes modify estimates of treatment toxicity. J Consult Clin Psychol 1992;60:477-80. [back]

238. Ilveskoski I, Pihko H, Wiklund T, Lamminranta S, Perkkio M, Makipernan A, et al. Neuropsychologic late effects in children with malignant brain tumors treated with surgery, radiotherapy and ‘8 in 1’ chemotherapy. Neuropediatrics 1996;27:124-9. [back]

239. Garcia-Perez A, Sierrasesumaga L, Narbona-Garcia J, Calvo-Manuel F, Aguirre-Ventallo M. Neuropsychological evaluation of children with intracranial tumors:impact of treatment modalities. Med Pediatr Oncol 1994;23(2):116-23. [back]

240. Davidson A, Childs J, Hopewell JW, Tait D. Functional neurological outcome in leukaemic children receiving repeated cranial irradiation. Radiother Oncol 1994;31: 101-9. [back]

241. Eiser C. Psychological sequelae of brain tumours in childhood: a retrospective study. Br J Clin Psychol 1981;20(1):35-8. [back]

242. Mulhern RK, Wasserman AL, Friedman AG, Fairclough D. Social competence and behavioral adjustment of children who are long-term survivors of cancer. Pediatrics 1989;83(1):18-25. [back]

243. Hill JM, Kornblith AB, Jones D, Freeman A, Holland JF, Glicksman AS, et al. A comparative study of the long term psychosocial functioning of childhood acute lymphoblastic leukemia survivors treated by intrathecal methotrexate with or without cranial radiation. Cancer 1998;82(1):208-18. [back]

244. Boman K, Bodegard G. Psychological long-term coping with experience of disease and treatment in childhood cancer survivors. Acta Paediatr 1995;84:1395-402. [back]

245. Fobair P, Hoppe RT, Bloom J, Cox R, Varghese A, Spiegel D. Psychosocial problems among survivors of Hodgkin’s disease. J Clin Oncol 1986;4:805-14. [back]

246. Madan-Swain A, Brown RT, Foster MA, Vega R, Byars K, Rodenberger W, et al. Identity in adolescent survivors of childhood cancer. J Pediatr Psychol 2000;25:105-15. [back]

247. Wasserman AL, Thompson EI, Wilimas JA, Fairclough DL. The psychological status of survivors of childhood/adolescent Hodgkin’s disease. Am J Dis Child 1987;141:626-31. [back]

248. Gogan JL, et al. Pediatric cancer survival and marriage: Issues affecting adult adjustment. Am J Orthopsychiatry 1979;49:423-30. [back]

249. Jenkin D, Danjoux C, Greenberg M. Subsequent quality of life for children irradiated for a brain tumor before age four years. Med Pediatr Oncol 1998;31:506-11. [back]

250. Zeltzer LK, Chen E, Weiss R, Guo MD, Robison LL, Meadows AT, et al. Comparison of psychologic outcome in adult survivors of childhood acute lymphoblastic leukemia versus sibling controls: a cooperative Children’s Cancer Group and National Institutes of Health study. J Clin Oncol 1997;15:547-56. [back]

251. Gray RE, Doan BD, Shermer P, FitzGerald AV, Berry MP, Jenkin D, et al. Psychologic adaptation of survivors of childhood cancer. Cancer 1992;70:2713-21. [back]

252. Kaleita TA, Reaman GH, MacLean WE, Sather HN, Whitt JK. Neurodevelopmental outcome of infants with acute lymphoblastic leukemia: a Children’s Cancer Group report. Cancer 1999;85:1859-65. [back]

253. Peper M, Steinvorth S, Schraube P, Fruehauf S, Haas R, Kimmig BN, et al. Neurobehavioral toxicity of total body irradiation: a follow-up in long-term survivors. Int J Radiat Oncol Biol Phys 2000;46:303-11. [back]

254. Rauck AM, Green DM, Yasui Y, Mertens A, Robison LL. Marriage in the survivors of childhood cancer: a preliminary description from the Childhood Cancer Survivor Study. Med Pediatr Oncol 1999;33:60-3. [back]

255. Elkin TD, Phipps S, Mulhern RK, Fairclough D. Psychological functioning of adolescent and young adult survivors of pediatric malignancy. Med Pediatr Oncol 1997;29:582-8. [back]

256. Arvidson J, Kihlgren M, Hall C, Lonnerholm G. Neuropsychological functioning after treatment for hematological malignancies in childhood, including autologous bone marrow transplantation. Pediatr Hematol Oncol 1999;16:9-21. [back]

257. Olson AL, Boyle WE, Evans MW, Zug LA. Overall function in rural childhood cancer survivors. The role of social competence and emotional health. Clin Pediatr (Phila) 1993;32:334-42. [back]

258. Anderson SI, Taylor R, Whittle IR. Mood disorders in patients after treatment for primary intracranial tumours. Br J Neurosurg 1999;13:480-5. [back]

259. Sawyer M, Antoniou G, Toogood I, Rice M. Childhood cancer: A two-year prospective study of the psychological adjustment of children and parents. J Am Acad Child Adolesc Psychiatry 1997;36:1736-43. [back]

260. Glaser AW, Abdul Rashid NF, Walker DA. School behaviour and health status after central nervous system tumours in childhood. Br J Cancer 1997;76:643-50. [back]

261. Hays DM, Landsverk J, Sallan SE, Hewett KD, Patenaude AF, Schoonover D, et al. Educational, occupational, and insurance status of childhood cancer survivors in their fourth and fifth decades of life. J Clin Oncol 1992;10(9):1397-406. [back]

262. Anholt UV, Fritz GK, Keener M. Self-concept in survivors of childhood and adolescent cancer. Journal of Psychosocial Oncology 1993;11:1-16. [back]

263. Williams KS, Ochs J, Williams JM, Mulhern RK. Parental report of everyday cognitive abilities among children treated for acute lymphoblastic leukemia. J Pediatr Psychol 1991;16:13-26. [back]

264. Pendley JS, Dahlquist LM, Dreyer Z. Body image and psychosocial adjustment in adolescent cancer survivors. J Pediatr Psychol 1997;22:29-43. [back]

265. Sloper T, Larcombe IJ, Charlton A. Psychosocial adjustment of five-year survivors of childhood cancer. J Cancer Educ 1994;9:163-9. [back]

266. Teta MJ, Del Po MC, Kasl SV, Meigs JW, Myers MH, Mulvihill JJ. Psychosocial consequences of childhood and adolescent cancer survival. J Chronic Dis 1986;39:751-9. [back]

267. Pelcovitz D, Libov BG, Mandel F, Kaplan S, Weinblatt M, Septimus A. Posttraumatic stress disorder and family functioning in adolescent cancer. J Trauma Stress 1998;11:205-21. [back]

268. Kazak AE. Posttraumatic distress in childhood cancer survivors and their parents. Med Pediatr Oncol 1998;Suppl 1:60-8. [back]

269. Barakat LP, Kazak AE, Meadows AT, Casey R, Meeske K, Stuber ML. Families surviving childhood cancer: A comparison of posttraumatic stress symptoms with families of healthy children. J Pediatr Psychol 1997;22:843-59. [back]

270. Kazak AE, Meadows AT. Families of young adolescents who have survived cancer: social-emotional adjustment, adaptability, and social support. J Pediatr Psychol 1989;14:175-91. [back]

271. Eiser C, Hill J, Blacklay A. Surviving cancer: What does it mean for you? An evaluation of a clinic based intervention for survivors of childhood cancer. Psychooncology 2000;9:214-20. [back]

272. Kazak AE, Simms S, Barakat L, Hobbie W, Foley B, Golomb V, et al. Surviving cancer competently intervention program (SCCIP): a cognitive-behavioral and family therapy intervention for adolescent survivors of childhood cancer and their families. Fam Process 1999;38:175-91. [back]

273. Rothbart-Mayer R, Olivo EL, Woolverton K, Ostroff J, Lesko L, Cabat T, et al. The reunion day: a workshop for survivors of childhood cancer and their families. J Psychosocial Oncol 2000;18:83-91. [back]

[Contents][Back][Top]

Scottish Intercollegiate Guidelines Network
Home